MedTrace Logo

Metabolomics of Obstructive Sleep Apnea

NCT04572269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 388

Last updated 2026-05-14

No results posted yet for this study

Summary

This is an R01 funded project that focuses on the utility of metabolomics as a biomarker for OSA. Aims 1 and 3 leverages banked samples previously collected from subjects with and without OSA at the University of Pennsylvania and University of Iceland. Aim 2 is a prospective study that will collect serum samples from OSA subjects at the University of Pennsylvania and the University of Iceland.

Conditions

Interventions

OTHER

No Intervention

This protocol does not involve an intervention of drug/device, diet, exercise or PAP compliance.

Sponsors & Collaborators

Principal Investigators

  • Allan Pack, MBChB, PhD · University of Pennsylvania

  • Aalim Weljie, PhD · University of Pennsylvania

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2025-09-12
Completion
2025-09-12

Countries

  • United States
  • Iceland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04572269 on ClinicalTrials.gov